Loading
A phase 3 trial of thalidomide, nab-paclitaxel and gemcitabine in pancreatic cancer, run by Fudan University, now recruiting.
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer is a phase 3, randomised interventional study registered as NCT06017284 by Fudan University, with a registry enrolment figure of 100 participants, started 2023-11-01 and due to reach its primary completion in 2025-11-30. Interventions recorded: Thalidomide; Nab paclitaxel; Gemcitabine; Placebo. Conditions listed: Pancreatic Cancer Stage IV; Chemotherapy-induced Nausea and Vomiting. Primary outcome: Rate of nausea/vomiting. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed metastatic pancreas adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.